Genentech chooses Fluor Daniel for strategic alliance
Marlton, NJ–Fluor Daniel, Inc., the principal subsidiary of Fluor Corp., a global engineering, construction and diversified services company, recently announced that its PharmBio & Chemicals operating company has been selected for a strategic engineering alliance by Genentech to provide project-related engineering services to its manufacturing, and R&D facilities in South San Francisco. As part of the new alliance, Fluor Daniel will also provide support staffing and project management services from its South San Francisco regional office. Fluor Daniel`s PharmBio & Chemicals operating company provides engineering, procurement, construction and validation, and strategic consulting services to pharmaceutical and biotechnology clients worldwide. Genentech, Inc., headquartered in South San Francisco, is a biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs.